Bacteriophage Therapy Market 2025 Bacteriophage Therapy Market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% by (2023-2030). BURLINGAME, CA, UNITED ...

Scientists develop DNA nanorobots capable of modifying artificial cells. Scientists at the University of Stuttgart have successfully used “DNA origami” to control the structure and function of ...

Gene therapy has been available since 2022 for hemophilia B and since 2023 for hemophilia A, yet some major medical institutions have barely treated any patients so far. What’s the holdup?

Wright said. It may be, she added, that weekly therapy sessions are simply not scalable to a broad population, and the field should explore light-touch alternatives, like single-session ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.

Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and ...

And of the dozen or so approved gene therapies in the U.S., only one, Novartis’ Zolgensma, is currently a blockbuster. (Sarepta Therapeutics’ Elevidys could become one this year.) Yescarta, a cancer ...

Ashley is mentored by WKU faculty Dr. Tony Simpao in the Department of Physics & Astronomy. Ava Blackledge (’25, Rowan County Senior High School) presented “Functional Characterization of a ...

The first human trial of insulin-producing cells that have been gene-edited to evade immune attack is a success so far. The cells have survived and produced insulin for a month after being ...

According to a new report, Bacteriophage Therapy Market will grow from US$ 1,280.9 million in 2023 to US$ 1,651.8 million by 2030 at a compounded annual growth rate (CAGR) of 3.7% during the forecast ...